“Geisinger is prescribing DNA sequencing to patients and putting DNA results in electronic health records and actually creating an action plan to prevent that predisposition from occurring. We are preventing disease from happening,” said Wendy Wilson, a Geisinger spokeswoman.
The Danville, Pennsylvania-based system plans to work with rabbittransit to help patients get to their appointments on time. Additionally, researchers from Geisinger and Regeneron Genetics Center recently found a gene variant that's associated with a reduction in the risk for chronic liver disease.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
In a recent phone interview, Geisinger President and CEO Dr. David Feinberg chatted about his organization's recent National Symposium, its National Precision Health Initiative and what's on the horizon in 2018.
In a recent phone interview, Geisinger's new chief innovation officer, Karen Murphy, discussed her new role and the future of healthcare transformation.
Geisinger Health System announced this week that it’s working with Regeneron Pharmaceuticals (NASDAQ: REGN) in a project to use genetic samples from more than 100,000 volunteers to identify and validate associations between genes and human disease. The move reflects Geisinger’s efforts to advance genomic analysis from the research stage to the point where it is […]
A molecular diagnostics company is raising fresh capital for a test to predict the likelihood of a precancerous condition becoming esophageal cancer. The idea is that by detecting the condition earlier and more accurately, it could lead to better outcomes. Cernostics’ approach is called TissueCipher Pathology. It combines digital imaging pathology, fluorescence biomarkers, informatics and […]
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.